Smart and Connected Equipment is growing at 18.59% a year in the global neonatal infant care equipment market, the fastest of any technology line the study tracks. It is taking ground from Conventional/Standalone Equipment, which still accounts for 82% of 2025 revenue at USD 2624 million.
Contrive Datum Insights sizes the market at USD 3200 million in 2025. Revenue rises from USD 3520 million in 2026 to USD 7040 million by 2034, a compound annual growth rate of 9.05% across the forecast period. The market covers incubators, infant warmers, phototherapy units, respiratory support devices and monitoring systems used to stabilize and treat newborns, particularly premature or low-birth-weight infants. Hospitals buy most of it, holding 78% of 2025 revenue at USD 2496 million.
Why the connected lines are pulling ahead
The study names rising preterm birth rates and NICU admissions as the largest single contributor to growth and rates its impact high. The product lines closest to that demand move fastest. Monitoring Devices compounds at 10.74%, lifting its share of revenue from 20% to 23% and its value from USD 640 million to USD 1619 million.
The same pattern shows up on other axes. Infection and Sepsis Management grows at 12.11% among applications, Nursing Homes at 12.89% among end users, and Distributors and Dealers at 11.73% among distribution channels. Prematurity and Low Birth Weight Care remains the largest application, with 34% of 2025 revenue at USD 1088 million.
The scenarios hinge on the same demand. If preterm birth rates in Asia Pacific and the Middle East climb faster than assumed and hospitals expand NICU beds ahead of normal capital-budget cycles, 2034 revenue reaches USD 7955 million. If public health budgets for maternal-neonatal care tighten and hospitals defer replacements, the move toward connected monitoring and higher-priced respiratory devices slows, and 2034 revenue holds at USD 6195 million.
Regions and the slower base
North America led in 2025 with 38% of global revenue, or USD 1216 million, and reaches USD 2323 million by 2034. The United States is the largest single country market at USD 1034 million, 32.31% of the global total. Asia Pacific gains the most ground, moving from 28% of revenue in 2025 to 34% in 2034 as its value grows from USD 896 million to USD 2394 million. Middle East and Africa stays the smallest region throughout, at 4% in 2025 and 5% by 2034.
The weight of the existing installed base acts as the counterweight. Respiratory Devices is the largest product line, with 30% of 2025 revenue at USD 960 million, and it still holds 33% in 2034. Incubators, at 28% of 2025 revenue, grow at only 7.68% against the market's 9.05%. Much of the added revenue therefore comes from monitoring, connected equipment and the regions still gaining share.
The report covers five segmentation axes with revenue and a growth rate for every line in every year from 2020 to 2034, bear, base and bull scenarios, all five regions with country-level breakdowns, the competitive landscape and the research methodology behind every estimate. It is delivered as a PDF, and a free sample is available on request.